SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The future of drug discovery and development: Shifting emphasis towards personalized medicine
4 references·5 citing·39 second hop
The future of drug discovery and development: Shifting emphasis towards personalized medicine (2009)The future of drug discovery and developm…Best Practice Guidelines on Publication Ethics: a Publisher's Perspective (2006)Best Practice Guidelines on P…The power of business models (2005)The power of business modelsKey factors in the rising cost of new drug discovery and development (2004)Key factors in the rising cos…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …The Promises and Challenges toward Mass Customization of Healthcare Services (2024)The Promises and Challenges t…Uncovering the dynamics of market convergence through M&A (2018)Uncovering the dynamics of ma…The knowledge production model of the New Sciences: The case of Translational Medicine (2016)The knowledge production mode…Problem-driven innovations in drug discovery: Co-evolution of the patterns of radical innovation with the evolution of problems (2016)Problem-driven innovations in…How stakeholder shape innovation in controversial industries: the biotechnology industry in Germany (2014)How stakeholder shape innovat…The rise and fall of strategic planning (1995)Strategy and the Internet. (2001)Value creation in E‐business (2001)Developing a unified framework of the business model concept (2010)A Critical Assessment of Business Model Research (2017)A Stakeholder Theory Perspective on Business Models: Value Creation for Sustainability (2019)Cost of innovation in the pharmaceutical industry (1991)Pharmaceutical pricing policies in a global market (2008)National Conference of State Legislatures (2011)The pharmaceutical technology landscape: A new form of technology roadmapping (2012)Changing R&D models in research-based pharmaceutical companies (2016)Competitive Strategy: Techniques for Analyzing Industries and Competitors (1980)Managing Legitimacy: Strategic and Institutional Approaches (1995)Strategic management a stakeholder approach (2010)Technological paradigms and technological trajectories (1982)Governing the Commons: The Evolution of Institutions for Collective Action (1992)Theory Building From Cases: Opportunities And Challenges (2007)Comparative Incentive Systems (2019)Theories of Development (2019)New Directions in Quantum Technologies (2022)Little Science, Big Science (1963)Imre Lakatos and Musgrave Alan (eds.). Criticism and the growth of knowledge. Cambridge: Cambridge University Press, 1970. 282 pp. np. (1972)Science for the post-normal age (1993)Unleashing Knowledge Sharing in Emerging Economy Startups: A Multilevel Analysis (2023)Tree knowledge structure for better insight: Capturing biomedical science-technology knowledge linkage with MeSH (2024)Recombinant Uncertainty in Technological Search (2001)In Search of Complementarity in Innovation Strategy: Internal R&D and External Knowledge Acquisition (2006)Big data analytics: Understanding its capabilities and potential benefits for healthcare organizations (2016)Assessing emerging sustainability-oriented technologies: the case of precision agriculture (2024)Discovering firm technology opportunities by machine learning prediction method based on firm's technology portfolio (2025)Small Area Variations in Health Care Delivery (1973)The World Health report 2006 1 : Working together for health 2 (2006)Rankings and Reactivity: How Public Measures Recreate Social Worlds (2007)Can the pharmaceutical industry reduce attrition rates? (2004)Clinical development success rates for investigational drugs (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Use of the h index in neurosurgery (2009)Muscle, Ligaments and Tendons Journal. Basic principles and recommendations in clinical and field science research. (2013)Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015 (2015)
this work references cited by second hop

References

  • 2003The price of innovation: new estimates of drug development costs4,264 cited
  • 2005The power of business models1,593 cited
  • 2004Key factors in the rising cost of new drug discovery and development499 cited
  • 2006Best Practice Guidelines on Publication Ethics: a Publisher's Perspective231 cited

Cited by

  • 2016Problem-driven innovations in drug discovery: Co-evolution of the patterns of radical innovation with the evolution of problems94 cited
  • 2018Uncovering the dynamics of market convergence through M&A36 cited
  • 2014How stakeholder shape innovation in controversial industries: the biotechnology industry in Germany10 cited
  • 2016The knowledge production model of the New Sciences: The case of Translational Medicine9 cited
  • 2024The Promises and Challenges toward Mass Customization of Healthcare Services5 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work